(Q43798526)

26 November 2017

title

The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein (English)

1 reference

26 November 2017

1 reference

1 reference

4

Vladimir N Uversky

1 reference

26 November 2017

Amy B Manning-Bog

1

1 reference

26 November 2017

Alison L McCormack

2

1 reference

26 November 2017

Jie Li

3

1 reference

26 November 2017

Anthony L Fink

5

1 reference

26 November 2017

Donato A Di Monte

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

13 November 2001

1 reference

Journal of Biological Chemistry

26 November 2017

published in

1 reference

26 November 2017

volume

277

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

1641-1644

1 reference

Alpha-synuclein in Lewy bodies

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Evidence for a partially folded intermediate in alpha-synuclein fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Environmental risk factors and Parkinson's disease: a case-control study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Parkinson's disease: a case-control study of occupational and environmental risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Paraquat: model for oxidant-initiated toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Paraquat: a useful tool for the in vivo study of mechanisms of neuronal cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Influence of age on the passage of paraquat through the blood-brain barrier in rats: a distribution and pathological examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Carrier-mediated processes in blood--brain barrier penetration and neural uptake of paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C100560200

21 January 2018

Identifiers

DOI

10.1074/JBC.C100560200

1 reference

26 November 2017

1 reference